TLR4 and cancer: TLR4 has been associated with cancer progression [49,50] and shown to be overexpressed or aberrantly expressed in breast, colon, ovarian, liver, and other cancer cell types [50]; however, to date, a direct link between the XOS antitumor effect and TLR4 or an interaction between XOS and TLR4 has not been reported.